Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Pharmacol ; 145(5): 656-63, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15834439

RESUMO

1. Antagonizing glutamatergic neurotransmission by blockade of AMPA-type glutamate receptors (GluR) is a promising pharmacological strategy for neuroprotection in neurodegenerative diseases and acute treatment of stroke. 2. We investigated the interaction of the adamantane derivative IEM-1460 with human wild-type and mutant AMPA-type GluR channels. Different recombinant homooligomeric human AMPA-type GluR channels and a rat nondesensitizing mutant GluR (GluR2 L504Y) channel were expressed in HEK293 cells and investigated using the patch-clamp technique in combination with ultrafast agonist application. 3. When IEM-1460 was coapplied with glutamate, an open channel block mechanism was observed at slow desensitizing GluR2 flip (>/=0.1 mM IEM-1460) and nondesensitizing GluR2 L504Y channels (>/=1 microM IEM-1460). 4. A competitive block of AMPA-type channels was observed with IC(50) values for the dose block curves of 0.1 mM IEM-1460 at human unmutated and 10 microM IEM-1460 at mutant GluR channels. 5. Nondesensitizing GluR2 L504Y channels were used to further characterize the block mechanism. After equilibration with the agonist, a current decay upon coapplication of glutamate and IEM-1460 was observed. The recovery from block was independent of the glutamate and IEM-1460 concentration. The extent of current inhibition as well as the time constant of current decay upon addition of the blocker to the test solution were dependent on agonist concentration; this strongly points to an additional competitive-like block mechanism of IEM-1460 at human AMPA-type GluR channels. 6. The data were interpreted in the frame of a molecular scheme with two binding sites of IEM-1460 at the receptor, one at the unliganded resting and the other at the fully liganded open state of the channels.


Assuntos
Adamantano/análogos & derivados , Adamantano/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Receptores de AMPA/antagonistas & inibidores , Adamantano/síntese química , Animais , Ligação Competitiva/efeitos dos fármacos , Linhagem Celular , Relação Dose-Resposta a Droga , Eletrofisiologia , Antagonistas de Aminoácidos Excitatórios/síntese química , Humanos , Potenciais da Membrana/efeitos dos fármacos , Técnicas de Patch-Clamp , Ratos , Receptores de AMPA/genética
2.
Synapse ; 55(3): 176-82, 2005 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-15635696

RESUMO

AMPA-type glutamate receptor (GluR) channels are the most abundant excitatory transmitter receptors of the central nervous system. Four subunits with different posttranscriptional modifications and flip/flop splice variants are known. In vivo they occur as tetrameric heteromeric receptors. In the present study we analyzed the time course of desensitization (tau(D)) and resensitization (tau(rec)) kinetics of different homomeric (coassembly of splice or editing variants of one subunit) and heteromeric (coassembly of different subunits) GluR channels. We found that tau(D) had intermediate values depending on the amount of cDNA of the respective subunit at all heteromeric and homomeric GluR channels tested. The same holds true for tau(rec) except GluR2 flip channels were coexpressed with GluR1 channels. In this case, tau(rec) had values close to that of fast resensitizing GluR2 flip channels, even in the case of an abundance of GluR1 cDNA.


Assuntos
Membrana Celular/metabolismo , Sistema Nervoso Central/metabolismo , Neurônios/metabolismo , Subunidades Proteicas/metabolismo , Receptores de AMPA/metabolismo , Transmissão Sináptica/genética , Processamento Alternativo/genética , Linhagem Celular , DNA Complementar/genética , Humanos , Cinética , Potenciais da Membrana/genética , Técnicas de Patch-Clamp , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Subunidades Proteicas/genética , Receptores de AMPA/genética , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...